Hinge Health (HNGE) president covers RSU taxes with 1,429 share withholding

Rhea-AI Filing Summary

Hinge Health, Inc. president James Pursley reported an exempt tax-withholding transaction involving company stock. On 02/01/2026, 1,429 shares of Class A Common Stock were withheld at $34.90 per share to cover federal and state tax obligations from vesting restricted stock units.

These shares were relinquished by Pursley and cancelled by Hinge Health in exchange for the company paying his related tax liabilities. After this administrative transaction, he beneficially owned 767,231 shares of Class A Common Stock directly.

Insider Trade Summary

Net Seller: 1,429 shares

Net Sell 1 txn

Insider Pursley James

Role President

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Class A Common Stock	1,429	$34.90	$50K

Holdings After Transaction: Class A Common Stock — 767,231 shares (Direct)

Footnotes (1)

1. F1. Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units.

FAQ

What insider transaction did HNGE president James Pursley report?

James Pursley reported an exempt tax-withholding transaction. Hinge Health, Inc. withheld and cancelled 1,429 Class A Common shares on 02/01/2026 to cover tax obligations arising from vesting restricted stock units, rather than an open-market sale.

How many Hinge Health (HNGE) shares were involved in the Form 4?

The Form 4 shows 1,429 shares of Hinge Health Class A Common Stock disposed of. These shares were withheld and cancelled by the company at $34.90 per share to satisfy federal and state tax withholding from RSU vesting.

Did Hinge Health president James Pursley sell HNGE shares on the open market?

No, the filing describes an exempt tax-withholding transaction under Section 16b-3(e). Shares were relinquished to Hinge Health and cancelled so the company could pay Pursley’s tax obligations from vesting restricted stock units, not an open-market stock sale.

How many HNGE shares does James Pursley own after this transaction?

Following the reported transaction, James Pursley beneficially owns 767,231 shares of Hinge Health Class A Common Stock directly. This reflects his holdings after 1,429 shares were withheld and cancelled to cover tax liabilities tied to RSU vesting.

Why is the HNGE Form 4 transaction marked as exempt under Section 16b-3(e)?

It is exempt because the transaction represents shares withheld to pay tax obligations on equity compensation. Under Section 16b-3(e), such withholdings related to vesting restricted stock units are treated as exempt dispositions, not typical discretionary sales in the market.

What price per share was used for the HNGE tax-withholding shares?

The Form 4 reports a price of $34.90 per share for the 1,429 Class A Common shares withheld. This value is used to determine the total amount applied toward the federal and state tax withholding obligations from the vesting restricted stock units.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 02/03/2026 - 08:45 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pursley James

(Last) (First) (Middle)

C/O HINGE HEALTH, INC.

455 MARKET STREET, SUITE 700

(Street)

SAN FRANCISCO CA 94105

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

3. Date of Earliest Transaction (Month/Day/Year)
02/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	02/01/2026		F(1)		1,429	D	$34.9	767,231	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units.

	/s/ James Budge, Attorney-in-Fact	02/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.